Balyasny Asset Management’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,285
Closed -$395K 1962
2023
Q4
$395K Buy
+19,285
New +$395K ﹤0.01% 1513